X0206 3/A 2015-07-27 2015-08-03 0 0001114220 KERYX BIOPHARMACEUTICALS INC KERX 0001537670 Holmes Scott A C/O KERYX BIOPHARMACEUTICALS, INC. 750 LEXINGTON AVENUE NEW YORK NY 10022 0 1 0 0 Chief Financial Officer Stock Options (Right to Buy) 7.66 2016-07-27 2025-07-27 Common Stock 100000 D The options vest according to the following schedule: one-third of the 100,000 options vest on July 27, 2016, and the remaining shares vest in equal quarterly installments through the third anniversary of the start date on July 27, 2018. This Form 3/A is being filed to amend an incorrect stock option exercise price as reported on the original Form 3, filed on August 3, 2015. /s/ Brian Adams, Attorney-in-Fact 2015-08-04